[Alpha Tau in Globe Newswire] Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

JERUSALEM, Nov. 19, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT^®, reported third quarter 2024 financial results and provided a corporate update.

Read more here.